Table 1.
Variable | Controls (N = 1199) n (%) |
Patients (N = 394) n (%) |
p Value |
---|---|---|---|
Age (years) | |||
≥55 | 912 (76.1%) | 307 (77.9%) | 0.451 |
Gender | |||
Male | 839 (70%) | 273 (69.3%) | 0.797 |
Cigarette smoking | |||
Yes | 471 (39.3%) | 156 (39.6%) | 0.913 |
Alcohol consumption | |||
Yes | 169 (14.1%) | 139 (35.3%) | <0.001 * |
HBsAg | |||
Positive | 146 (12.2%) | 167 (42.4%) | <0.001 * |
Anti-HCV | |||
Positive | 53 (4.4%) | 178 (45.2%) | <0.001 * |
AFP (ng/mL) a | 20.83 | ||
AST (IU/L) a | 48 | ||
ALT (IU/L) a | 43 | ||
Stage | |||
III + IV | 117 (29.7%) | ||
Tumor T status | |||
T3 + T4 | 112 (28.4%) | ||
Lymph node status | |||
N1 + N2 + N3 | 12 (3%) | ||
Metastasis | |||
M1 | 19 (4.8%) | ||
Child–Pugh grade | |||
B or C | 74 (18.8%) | ||
Liver cirrhosis | |||
Positive | 326 (82.7%) |
Mann–Whitney U-test or Chi-squared test was used between healthy controls and patients with HCC. * p value < 0.05 as statistically significant. a Median level. HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; AFP, alpha-fetoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase.